| Today's Top Story |  |  | |  | HEALTHY CASH FLOW SOLUTIONS FOR YOUR BUSINESS
The Enhanced Plum Card from American Express OPEN®
Flexible Payment Terms:
• Get a 1.5% Early Pay Discount
• Take up to 60 Days to Pay with No Interest
Limited Time Offer: Get up to a 2% Discount: 1.5% Early Pay Discount plus, for the first 6 months, get an extra 0.5% on purchases†.
LEARN MORE †Terms and Restrictions Apply. |
  | Health Care & Policy | | | | - Oncolytics lung cancer drug Reolysin shows promise in Phase II study
Oncolytics Biotech will continue a midstage trial of its experimental squamous cell lung cancer therapy Reolysin after the drug achieved the main goal of showing patient response during the first part of the study. Reolysin was given in combination with chemotherapy treatments carboplatin and paclitaxel. Reuters (9/13)       - Investor to startups: Use your science boards wisely
 Many biotech startups do not use their scientific advisory boards to their full advantage, missing an opportunity to better shape their portfolios and programs, writes Bruce Booth, a partner at Atlas Venture. Booth polled a few fellow investors and describes what they see as the most advantageous ways biotechs can use their SABs. Forbes (9/10) - Stem cells repair nerves and restore hearing in animal study
Auditory nerve cells created from human stem cells reconnected the inner ear to the brain in gerbils, restoring hearing in the animals, researchers said. Transplanted cells formed connections to the brain within 10 weeks of implantation, and the procedure improved hearing by 46%. "More work needs to be done, but now we know it's possible," said lead author Dr. Marcelo Rivolta of the University of Sheffield in the U.K. Nature (9/12) | Company & Financial News | | | | - Grant will support research on tracking of transplanted cells
The National Cancer Institute has awarded the Molecular Imaging Center at Washington University School of Medicine in St. Louis a five-year, $7.1 million grant in support of studies that will focus on monitoring cells and proteins linked to diseases. Researchers are working on ways to follow cells and proteins inside the body. One program is exploring the use of labeling immune cells in donors' bone marrow to allow monitoring after transplantation in studies of graft-versus-host disease. MolecularImaging.net (9/12)
| Food & Agriculture | | | | | Industrial & Environmental | | | | - $3B bioenergy project is envisioned for tribal lands
The Council of Energy Resource Tribes has signed a development agreement with BioJet and Tartoosh Environmental. The project's goals include the construction of about 10 biorefineries and five waste-to-energy plants on tribal lands at an expected cost of more than $3 billion. BiofuelsDigest.com (9/13) | News from BIO | | | | - Are you taking full advantage of your membership?
BIO's cost-savings program, BIO Business Solutions, is helping 2,700 companies nationwide save on the cost of essential products and services. Members of BIO and 43 state and regional biotech associations are eligible to receive preferential pricing and other benefits at no additional cost beyond their membership dues. VWR International, FedEx, Office Depot and Business Wire are just a few of the industry leading providers that offer special pricing through this members-only program. Learn more or enroll here.
| SmartQuote | | | |  | Many wealthy people are little more than janitors of their possessions."
--Frank Lloyd Wright,
American architect  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Thursday, September 13, 2012
- Wednesday, September 12, 2012
- Tuesday, September 11, 2012
- Monday, September 10, 2012
- Friday, September 07, 2012
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment